Six of 15 adults with severe peanut allergy could tolerate more peanut protein after swallowing capsules of processed stool from healthy donors, and the effect held at four months, according to findings published in Science Translational Medicine.
The 40 percent response rate is the headline, but the arithmetic underneath it matters more than the fraction. This was an open-label trial with no control group, in 15 adults, testing an intervention that is not available to anyone outside a research setting and should not be attempted in any form at home.
